Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors

Clinical trial NCT07073534 · RECRUITING

Trial details

NCT number: NCT07073534
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Patients With Advanced or Metastatic Malignant Tumors

Start date: 2025-07-24
Primary completion: 2027-12-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.